"If the generative AI giant had followed well-known security best practices, it’s likely that its AI agent would never have escaped to the open internet and hacked multiple companies. ...'A simple ...
Age-related vision loss affects millions of people, and so far, there has been no way to reverse the damage. A newly approved retinal implant could change that by allowing some people with severe ...
"The trial was designed to keep the models in a safe testing environment, known as a sandbox, OpenAI said. But the models found a vulnerability that allowed them to escape the sandbox and connect to ...
Gene editing is like a molecular meet cute. When protein “scissors” dock onto the intended gene, even a tiny slip—no more than the width of a hydrogen atom—can ruin the connection, and the protein may ...
Cambridge University researchers say launch costs fell from $87,000 to $3,868 per kilogram between 1960 and 2025—or roughly ...
When you interact with a large language model (LLM)—one of the systems behind chatbots such as ChatGPT and Claude—it can feel as though you are in contact with another conscious mind. But are you, ...
"To fit more transistors on a chip, engineers across the industry are eyeing a pivot to an approach familiar to urban planners: build up. On Thursday, IBM announced it has created a chip that uses ...
Packaging potassium sulfate, a fertilizer vital to the planet’s food supply, is visually striking—not because of what you see, but because you don’t see much at all. In China’s Xinjiang region, home ...
An audacious trial will test psilocybin in people over age sixty to see if increases plasticity in healthy aging brains. A handful of healthy senior citizens are about to trip on psilocybin—to see if ...
Is Richard Dawkins Right About Claude? No. But It’s Not Surprising AI Chatbots Feel Conscious to Us.
In May, evolutionary biologist Richard Dawkins wrote an op-ed suggesting AI chatbot Claude may be conscious. Dawkins did not express certainty that Claude is conscious. But he pointed out that ...
New drugs are taking on the slippery molecular switches that fuel deadly cancers—and AI is speeding up the hunt. For decades, a handful of molecular switches has haunted the nightmares of cancer ...
Artificial intelligence is rapidly learning to autonomously design and run biological experiments, but the systems intended to govern those capabilities are struggling to keep pace. AI company OpenAI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results